VANDA PHARMACEUTICALS INC.

Company

Vanda Pharmaceuticals Inc.

Filed

November 9, 2009

Accession Number

0001086364-09-000406

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →